# Booz Allen Hamilton Holding Corp: financial statements, quarterly

BAH · NYSE · CIK 1443646 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/bah.md) · [Financials](/companies/bah/financials.md) · [Filings](/companies/bah/filings.md) · [Insiders](/companies/bah/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bah/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,570](/filings/0001443646-25-000012.md) | [2,771 d](/filings/0001628280-26-037521.md) | [2,942](/filings/0001443646-25-000137.md) | [3,146](/filings/0001628280-25-046176.md) | [2,917](/filings/0001628280-26-003187.md) | [2,975 d](/filings/0001628280-26-037521.md) | [2,924](/filings/0001628280-26-049495.md) | [2,890](/filings/0001628280-26-066973.md) | [2,620](/filings/0001628280-26-003187.md) | [2,783 d](/filings/0001628280-26-037521.md) | [2,800](/filings/0001628280-26-049495.md) | [2,778](/filings/0001628280-26-066973.md) |
| Cost of revenue | $m | [1,181](/filings/0001443646-25-000012.md) | [1,255 d](/filings/0001628280-26-037521.md) | [1,372](/filings/0001443646-25-000137.md) | [1,362](/filings/0001628280-25-046176.md) | [1,305](/filings/0001628280-26-003187.md) | [1,380 d](/filings/0001628280-26-037521.md) | [1,423](/filings/0001628280-26-049495.md) | [1,340](/filings/0001628280-26-066973.md) | [1,259](/filings/0001628280-26-003187.md) | [1,283 d](/filings/0001628280-26-037521.md) | [1,336](/filings/0001628280-26-049495.md) | [1,333](/filings/0001628280-26-066973.md) |
| Operating income | $m | [248](/filings/0001443646-25-000012.md) | [265 d](/filings/0001628280-26-037521.md) | [255](/filings/0001443646-25-000137.md) | [549](/filings/0001628280-25-046176.md) | [291](/filings/0001628280-26-003187.md) | [275 d](/filings/0001628280-26-037521.md) | [257](/filings/0001628280-26-049495.md) | [283](/filings/0001628280-26-066973.md) | [230](/filings/0001628280-26-003187.md) | [263 d](/filings/0001628280-26-037521.md) | [279](/filings/0001628280-26-049495.md) | [245](/filings/0001628280-26-066973.md) |
| Interest expense | $m | [46.6](/filings/0001443646-24-000010.md) | [46.1 d](/filings/0001443646-24-000075.md) | [45.9](/filings/0001443646-24-000156.md) | [47.0](/filings/0001443646-24-000200.md) | [45.6](/filings/0001443646-25-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [61.7](/filings/0001443646-25-000012.md) | [91.7 d](/filings/0001628280-26-037521.md) | [49.0](/filings/0001443646-25-000137.md) | [123](/filings/0001628280-25-046176.md) | [61.0](/filings/0001628280-26-003187.md) | [51.0 d](/filings/0001628280-26-037521.md) | [(55.0)](/filings/0001628280-26-049495.md) | [58.0](/filings/0001628280-26-066973.md) | [(13.0)](/filings/0001628280-26-003187.md) | [21.0 d](/filings/0001628280-26-037521.md) | [53.0](/filings/0001628280-26-049495.md) | [18.0](/filings/0001628280-26-066973.md) |
| Net income | $m | [146](/filings/0001443646-25-000012.md) | [128 d](/filings/0001628280-26-037521.md) | [165](/filings/0001443646-25-000137.md) | [390](/filings/0001628280-25-046176.md) | [187](/filings/0001628280-26-003187.md) | [193 d](/filings/0001628280-26-037521.md) | [271](/filings/0001628280-26-049495.md) | [175](/filings/0001628280-26-066973.md) | [200](/filings/0001628280-26-003187.md) | [205 d](/filings/0001628280-26-037521.md) | [198](/filings/0001628280-26-049495.md) | [181](/filings/0001628280-26-066973.md) |
| Diluted EPS | $ per share | [1.11](/filings/0001443646-25-000012.md) | not reported | [1.27](/filings/0001443646-25-000137.md) | [3.01](/filings/0001628280-25-046176.md) | [1.45](/filings/0001628280-26-003187.md) | not reported | [2.16](/filings/0001628280-26-049495.md) | [1.42](/filings/0001628280-26-066973.md) | [1.63](/filings/0001628280-26-003187.md) | not reported | [1.63](/filings/0001628280-26-049495.md) | [1.50](/filings/0001628280-26-066973.md) |
| Basic EPS | $ per share | [1.11](/filings/0001443646-25-000012.md) | not reported | [1.27](/filings/0001443646-25-000137.md) | [3.02](/filings/0001628280-25-046176.md) | [1.46](/filings/0001628280-26-003187.md) | not reported | [2.17](/filings/0001628280-26-049495.md) | [1.42](/filings/0001628280-26-066973.md) | [1.64](/filings/0001628280-26-003187.md) | not reported | [1.63](/filings/0001628280-26-049495.md) | [1.50](/filings/0001628280-26-066973.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [602](/filings/0001443646-24-000010.md) | [554](/filings/0001443646-25-000076.md) | [298](/filings/0001443646-24-000156.md) | [559](/filings/0001443646-24-000200.md) | [454](/filings/0001443646-25-000012.md) | [885](/filings/0001628280-26-037521.md) | [711](/filings/0001443646-25-000137.md) | [816](/filings/0001628280-25-046176.md) | [882](/filings/0001628280-26-003187.md) | [728](/filings/0001628280-26-066973.md) | [540](/filings/0001628280-26-049495.md) | [334](/filings/0001628280-26-066973.md) |
| Current assets | $m | [2,677](/filings/0001443646-24-000010.md) | [2,739](/filings/0001443646-25-000076.md) | [2,701](/filings/0001443646-24-000156.md) | [2,917](/filings/0001443646-24-000200.md) | [2,846](/filings/0001443646-25-000012.md) | [3,313](/filings/0001628280-26-037521.md) | [3,135](/filings/0001443646-25-000137.md) | [3,221](/filings/0001628280-25-046176.md) | [3,077](/filings/0001628280-26-003187.md) | [2,961](/filings/0001628280-26-066973.md) | [3,040](/filings/0001628280-26-049495.md) | [2,884](/filings/0001628280-26-066973.md) |
| Total assets | $m | [6,475](/filings/0001443646-24-000010.md) | [6,564](/filings/0001443646-25-000076.md) | [6,641](/filings/0001443646-24-000156.md) | [6,878](/filings/0001443646-24-000200.md) | [6,821](/filings/0001443646-25-000012.md) | [7,312](/filings/0001628280-26-037521.md) | [7,170](/filings/0001443646-25-000137.md) | [7,153](/filings/0001628280-25-046176.md) | [7,051](/filings/0001628280-26-003187.md) | [7,118](/filings/0001628280-26-066973.md) | [7,610](/filings/0001628280-26-049495.md) | [8,308](/filings/0001628280-26-066973.md) |
| Current liabilities | $m | [1,597](/filings/0001443646-24-000010.md) | [1,692](/filings/0001443646-25-000076.md) | [1,737](/filings/0001443646-24-000156.md) | [1,875](/filings/0001443646-24-000200.md) | [1,814](/filings/0001443646-25-000012.md) | [1,846](/filings/0001628280-26-037521.md) | [1,760](/filings/0001443646-25-000137.md) | [1,834](/filings/0001628280-25-046176.md) | [1,703](/filings/0001628280-26-003187.md) | [1,663](/filings/0001628280-26-066973.md) | [1,906](/filings/0001628280-26-049495.md) | [2,010](/filings/0001628280-26-066973.md) |
| Total liabilities | $m | [5,388](/filings/0001443646-24-000010.md) | [5,517](/filings/0001443646-25-000076.md) | [5,557](/filings/0001443646-24-000156.md) | [5,678](/filings/0001443646-24-000200.md) | [5,611](/filings/0001443646-25-000012.md) | [6,309](/filings/0001628280-26-037521.md) | [6,105](/filings/0001443646-25-000137.md) | [6,157](/filings/0001628280-25-046176.md) | [6,026](/filings/0001628280-26-003187.md) | [6,013](/filings/0001628280-26-066973.md) | [6,408](/filings/0001628280-26-049495.md) | [7,064](/filings/0001628280-26-066973.md) |
| Long-term debt | $m | [3,370](/filings/0001443646-24-000010.md) | [3,350](/filings/0001443646-25-000076.md) | [3,330](/filings/0001443646-24-000156.md) | [3,311](/filings/0001443646-24-000200.md) | [3,291](/filings/0001443646-25-000012.md) | [3,915](/filings/0001628280-26-037521.md) | [3,896](/filings/0001443646-25-000137.md) | [3,877](/filings/0001628280-25-046176.md) | [3,857](/filings/0001628280-26-003187.md) | [3,921](/filings/0001628280-26-066973.md) | [3,917](/filings/0001628280-26-049495.md) | [4,391](/filings/0001628280-26-066973.md) |
| Current portion of debt | $m | [51.6](/filings/0001443646-24-000010.md) | [62.0](/filings/0001443646-25-000076.md) | [72.2](/filings/0001443646-24-000156.md) | [82.5](/filings/0001443646-24-000200.md) | [82.5](/filings/0001443646-25-000012.md) | [83.0](/filings/0001628280-26-037521.md) | [83.0](/filings/0001443646-25-000137.md) | [83.0](/filings/0001628280-25-046176.md) | [83.0](/filings/0001628280-26-003187.md) | [19.0](/filings/0001628280-26-066973.md) | [19.0](/filings/0001628280-26-049495.md) | [19.0](/filings/0001628280-26-066973.md) |
| Shareholders' equity | $m | [1,086](/filings/0001443646-24-000010.md) | [1,047](/filings/0001628280-26-003187.md) | [1,084](/filings/0001628280-25-046176.md) | [1,201](/filings/0001628280-26-003187.md) | [1,210](/filings/0001628280-26-003187.md) | [1,003](/filings/0001628280-26-066973.md) | [1,065](/filings/0001628280-26-066973.md) | [996](/filings/0001628280-26-066973.md) | [1,025](/filings/0001628280-26-003187.md) | [1,105](/filings/0001628280-26-066973.md) | [1,202](/filings/0001628280-26-066973.md) | [1,244](/filings/0001628280-26-066973.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [234 d](/filings/0001443646-25-000012.md) | [144 d](/filings/0001628280-26-037521.md) | [52.0](/filings/0001443646-25-000137.md) | [587 d](/filings/0001628280-25-046176.md) | [151 d](/filings/0001628280-26-003187.md) | [219 d](/filings/0001628280-26-037521.md) | [119](/filings/0001628280-26-049495.md) | [421 d](/filings/0001628280-26-066973.md) | [261 d](/filings/0001628280-26-003187.md) | [240 d](/filings/0001628280-26-037521.md) | [281](/filings/0001628280-26-049495.md) | [294 d](/filings/0001628280-26-066973.md) |
| Capital expenditure | $m | [23.1 d](/filings/0001443646-25-000012.md) | [16.5 d](/filings/0001628280-26-037521.md) | [32.0](/filings/0001443646-25-000137.md) | [24.0 d](/filings/0001628280-25-046176.md) | [17.0 d](/filings/0001628280-26-003187.md) | [25.0 d](/filings/0001628280-26-037521.md) | [23.0](/filings/0001628280-26-049495.md) | [26.0 d](/filings/0001628280-26-066973.md) | [13.0 d](/filings/0001628280-26-003187.md) | [28.0 d](/filings/0001628280-26-037521.md) | [20.0](/filings/0001628280-26-049495.md) | [31.0 d](/filings/0001628280-26-066973.md) |
| Dividends paid | $m | [61.7 d](/filings/0001443646-25-000012.md) | [67.2 d](/filings/0001628280-26-037521.md) | [66.0](/filings/0001443646-25-000137.md) | [67.0 d](/filings/0001628280-25-046176.md) | [65.0 d](/filings/0001628280-26-003187.md) | [70.0 d](/filings/0001628280-26-037521.md) | [70.0](/filings/0001628280-26-049495.md) | [68.0 d](/filings/0001628280-26-066973.md) | [67.0 d](/filings/0001628280-26-003187.md) | [71.0 d](/filings/0001628280-26-037521.md) | [73.0](/filings/0001628280-26-049495.md) | [72.0 d](/filings/0001628280-26-066973.md) |
| Share repurchases | $m | [94.5 d](/filings/0001443646-25-000012.md) | [100 d](/filings/0001628280-26-037521.md) | [116](/filings/0001443646-25-000137.md) | [232 d](/filings/0001628280-25-046176.md) | [149 d](/filings/0001628280-26-003187.md) | [315 d](/filings/0001628280-26-037521.md) | [181](/filings/0001628280-26-049495.md) | [214 d](/filings/0001628280-26-066973.md) | [126 d](/filings/0001628280-26-003187.md) | [77.0 d](/filings/0001628280-26-037521.md) | [72.0](/filings/0001628280-26-049495.md) | [98.0 d](/filings/0001628280-26-066973.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [133](/filings/0001443646-24-000010.md) | [132](/filings/0001443646-24-000156.md) | [131](/filings/0001443646-24-000200.md) | [130](/filings/0001443646-25-000012.md) | [130](/filings/0001443646-25-000137.md) | [129](/filings/0001628280-25-046176.md) | [128](/filings/0001628280-26-003187.md) | [124](/filings/0001628280-26-049495.md) | [123](/filings/0001628280-26-066973.md) | [121](/filings/0001628280-26-003187.md) | [120](/filings/0001628280-26-049495.md) | [120](/filings/0001628280-26-066973.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 118,602,638 at 2026-10-19, from the cover of the [10-Q filed 2026-10-23](/filings/0001628280-26-066973.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.